Moloney Securities Asset Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
Moloney Securities Asset Management's DGX Position: Q1 2022 in Review
Moloney Securities Asset Management sold out of Quest Diagnostics (DGX) in Q1 2022, closing a stake of 4,852 shares — an estimated $839K sold.
Moloney Securities Asset Management first reported a position in DGX in Q4 2016 and held it in 21 quarters. The position peaked at $839K in Q4 2021. 851 funds tracked by Wall St. Rank hold DGX as of Q1 2022.
- Moloney Securities Asset Management reported no remaining Quest Diagnostics position as of Q1 2022 after selling out during the quarter.
- Moloney Securities Asset Management sold 4,852 Quest Diagnostics shares in Q1 2022, an estimated $839K.
- Moloney Securities Asset Management first reported a position in Quest Diagnostics in Q4 2016 and held it in 21 quarters.
- Moloney Securities Asset Management's Quest Diagnostics position peaked at $839K in Q4 2021.
- 851 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2022.
Based on Moloney Securities Asset Management's 13F filing for Q1 2022, filed 10 May 2022.